Lungcast

0:16 Intro

2:24 Asthma action plans

3:52 Asthma Peak Week

6:28 School nurse’s role

11:05 SMART inhaler strategy for kids

14:25 Addressing vaping among students

20:18 Discussing vaccines with children and parents

24:01 School air quality issues?

27:50 Final thoughts

29:42 Outro

As families jump into the new school year, this episode brings together Chicago-based allergist and immunologist Dr. Juanita Mora and pediatric pulmonologist Dr. S. Christy Sadreameli of Johns Hopkins Hospital to share their tips for making the return to school as smooth as possible in regard to lung health. 

The lively conversation homes in on asthma control and the phenomenon often referred to as ‘peak week,’ along with the prevalence and hazards of vaping and e-cigarettes affecting the school aged population. Grab your pencils and take notes!

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:15 Introduction

2:35 Introducing Janelle Bludorn, MS, PA-C

3:27 Common heat-related illnesses

8:43 How to screen for individual health-related risks

15:27 Respiratory consequences of heat

19:49 The interplay of medicines with heat

26:49 National Weather Service HeatRisk tool

32:58 Behavioral interventions for heat-risk patients

36:27 A FEMA system for heat emergencies?

38:10 Outro

For our July episode, we are visited by Duke University’s Janelle Bludorn, PA-C, MS, for a comprehensive overview of heat-related respiratory illnesses. 

Due to climate change in all regions around the world, extreme heat has become a significant environmental and occupational health hazard with heatstroke classified as a medical emergency. Listen in to better understand the serious risks of exposure to high temperatures.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:15 Intro

3:39 Update in pre-lung cancer genome atlas research

17:06 Next steps: applying innovations in bronchoscopy

21:45 When we can anticipate results

25:05 Understanding the lung’s microbiome

29:21 Utility of fragmentomics

31:01 Outro

Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:16 Intro

2:29 Updated community-acquired pneumonia guidelines

5:41 Diagnostic tools for CAP following COVID-19

9:35 Procalcitonin levels as a biomarker

12:30 The CAP treatment algorithm

18:36 Best practices for antibiotic stewardship

20:40 New CAP therapies on the horizon

22:36 ACIP recommendations for vaccination

24:30 Remaining areas of CAP uncertainty

26:30 Final thoughts

27:25 Outro

Featuring infectious disease expert Dr. Thomas File of Summa Health in Ohio, this episode delves into how community-acquired pneumonia has been affected by the COVID-19 pandemic. It additionally covers the role and importance of antibiotic stewardship and the concern of ‘superbugs’ due to antimicrobial resistance.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:11 Intro

1:05 Introducing Stephanie Lovinsky-Desir, MD, MS

2:09 Understanding asthma endotypes and phenotypes

5:03 The effect of SMART guideline updates

11:50 Are pulmonary & allergy specialists adopting it?

12:46 The value of biologics in asthma care

18:11 Could they interrupt the atopic march?

19:53 COVID-19 risks in asthma

23:24 Environmental and non-viral illness impacts on asthma

26:11 Research into asthma care inequities

31:47 HFA-containing metered dose inhalers

35:37 Outro

In honor of World Asthma Day, Dr. Stephanie Lovinsky-Desir of Columbia University Irving Medical Center in New York visits our virtual studio to talk about all things asthma. Dr. Lovinsky-Desir, who has a deep understanding of how environmental factors impact children with asthma, touches upon inequities in asthma care, the role of climate change and COVID-19 lessons learned. She also hones in on whether biologic therapies may help interrupt pathways in the atopic march.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Episode Highlights

0:16 Intro

2:17 What caused the particle pollution spike?

6:28 The health effects of fine particle pollution exposure

10:23 The new EPA particle pollution standard

14:27 Improvements to ozone pollution and the Clean Air Act

18:46 How to advocate for improvement

20:23 Air quality inequity

24:03 Reflecting on 25 years, and looking ahead

25:52 Outro 

Dr. John Balmes, a renowned environmental health sciences expert from the University of California, San Francisco, join Lungcast for a deep dive into the American Lung Association’s newly released 2024 “State of the Air” report. Balmes specifically provides context behind several concerning trends, notably a spike in deadly particle pollution—the highest levels in the past 25 years largely due to wildfires. 

The eye-opening conversation also impresses upon the importance of clean transportation and power generation to help mitigate population-wide risk. 

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:16 Intro

2:28 Recent modifications to the lung allocation score

5:11 Monitoring chronic graft rejection

9:23 The rising use of ex vivo lung perfusion 

16:17 The presence of post-COVID patients on the lung transplant waitlist

21:01 Impact of long Covid on transplant rehabilitation

22:51 Double lung transplant in bilateral lung cancer—what’s the future?

26:52 Effect of LAS on lung transplant survival racial disparity

31:05 What lies ahead in the practice of lung transplantation

35:00 Outro

Cleveland Clinic’s Maryam Valapour, MD, MPP, rejoins the broadcast, along with her colleague Kenneth McCurry, MD to discuss optimization of the lung allocation system to continue reducing waitlist times and patient mortality. 

It includes commentary on how recent changes to scoring protocols are expected to impact ongoing disparities related to race and socioeconomic status. They additionally talk about the role of transplantation in patients who have severely damaged lungs resulting from COVID-19 infection, an update since our April 2021 conversation.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:15 Intro

3:09 Low-dose CT screening uptake in Canada

4:45 Evolution of adjuvant, neoadjuvant therapies

7:10 Reviewing CheckMate 816

10:56 Reviewing KEYNOTE-671

12:58 The impact of neoadjuvants on operability

16:15 Treatment-specific biomarkers for lung cancer

21:13 The short-term future of lung cancer therapy

24:31 Outro

Precision medicine–delivering the right drug at the right time to the right patient–is the direction in which lung cancer treatment is heading. In this episode, we talk about an exciting, emerging drug class with one of the most prominent investigators involved with its development, Dr. Jonathan Spicer at McGill University’s Thoracic Oncology Network. 

It provides a deep dive into neoadjuvant therapy for patients who have operable lung cancer, offering insight into what is currently known about response and failure rates.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:15 Intro

1:48 Remembering the 1964 Surgeon General Report

3:01 The impact of the report on cardiology

6:47 The strategies and impact of anti-smoking campaigns

10:33 The modern vaping challenge

17:38 Outro

In recognition of 60 years since the 1964 Surgeon General Report—a historic contribution to our understanding of the negative health impacts of cigarette smoking—host Albert Rizzo, MD, meets with preventive cardiology expert Viet Le, DMSc, PA-C to reflect on the myriad of cascading effects delivered by this landmark report.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:15 Introducing Sue Padernacht, EDd, PCC

1:16 The definition of burnout

3:53 The history of burnout

7:45 Differences between stress and burnout

14:34 Physical and behavioral signs of burnout

20:55 Steps the health care industry can take against burnout

We are beginning 2024 with a matter that extends beyond the confines of pulmonary medicine and really has become something of a crisis in the U.S. healthcare system over the last decades. Organizational psychology expert Dr. Sue Padernacht joins Lungcast to provide an in-depth look into physician burnout—what are its drivers, what factors are exacerbating it, and how the collective medical community can work toward curbing its effect among caregivers.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast